Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 49.2K | Apr 25, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZVRA | ZEVRA THERAPEUTICS, INC. | Apr 25, 2023 | 1 | $0 | 4 | May 8, 2023 | Director |
ZVRA | ZEVRA THERAPEUTICS, INC. | Mar 9, 2023 | 1 | $46.1K | 4 | Mar 13, 2023 | Director |
ZVRA | KEMPHARM, INC | Jun 28, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
ZVRA | KEMPHARM, INC | May 18, 2022 | 4 | $24.8K | 4 | May 18, 2022 | Director |
ZVRA | KEMPHARM, INC | Dec 1, 2021 | 1 | $21.1K | 4 | Dec 1, 2021 | Director |
ZVRA | KEMPHARM, INC | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |